News >

Tumor Sidedness Opens Door for Personalized Therapy in Colorectal Cancer

Brandon Scalea
Published: Monday, Jun 17, 2019

Sujatha Nallapareddy, MD

Sujatha Nallapareddy, MD

A better understanding of colorectal cancer (CRC) biology has allowed for more opportunities for personalized treatment approaches, which, in turn, has improved overall survival (OS) for patients, said Sujatha Nallapareddy, MD. However, more progress is needed in terms of identifying predictive biomarkers and effective combination strategies.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Advancing the Treatment of Bladder Cancers Using Evidence-Based Immuno-Oncology StrategiesJul 30, 20191.0
Medical Crossfire®: Where Are We Headed in the Treatment of Triple-Negative Breast Cancer?Jul 31, 20191.5
Publication Bottom Border
Border Publication
x